Publication

Theme Article

Theme II | Volume 27

Aging and Multiple Sclerosis: Multidisciplinary Care and Access to Care

Multidisciplinary care for older adults with multiple sclerosis should address geriatric issues, which can be done using a comprehensive geriatric assessment by providers in disciplines including but not limited to neurology, geriatrics, rehabilitation, social work, pharmacy, neuropsychology, psychology/psychiatry, nutrition, urology, ophthalmology, and audiology.

Abstract

Older adults with multiple sclerosis (MS) experience challenges across multiple aspects of health care, and health care delivery must evolve to meet the geriatric needs of the aging MS population. Although the literature on multidisciplinary care or access to care for older adults with MS is sparse, the geriatric care literature for the general population highlights the importance of comprehensive geriatric assessment and the barriers to health care. This review, based on a 2024 Consortium of MS Centers’ Consensus Statement committee meeting, discusses multidisciplinary care and key barriers to care for older adults with MS and integrates insights from the broader geriatric care literature. Clinical and policy-level recommendations are shared to enhance provider knowledge, improve care delivery, and support better outcomes for older adults living with MS.

From the Department of Neurological Sciences, University of Nebraska, Omaha, NE (RStewart); Independence Care System, Brooklyn, NY (RStacom); BronxCare Multiple Sclerosis Center, Bronx, New York (RStacom); Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Neurology, University of Colorado Anschutz School of Medicine, Aurora, CO (JB); UCHealth Yampa Valley Medical Center, Steamboat Springs, CO (PB); Department of Neurology, Georgetown University Medical Center, Washington, DC, (JW); Department of Neurosciences, University of California San Diego, San Diego, CA (JSG); private practice, Greensboro, NC (MDB); Departments of Internal Medicine and Geriatrics, University of Nebraska Medical Center, Omaha, NE (MTC); Department of Neurology, University of Colorado Anschutz School of Medicine, Aurora, CO (JRC); departments of Medicine and Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada (RAM); Nova Scotia Health, Halifax, Nova Scotia, Canada (RAM); Department of Clinical Neurology, Johns Hopkins School of Medicine, Baltimore, MD (SDN); Department of Neurology, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV (LHH); Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada (SAM); Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY (FWF); Multiple Sclerosis Center, Holy Name Medical Center, Teaneck, NJ (FWF); Division of MS/Neuroimmunology, The Ohio State University, Wexner Medical Center, Columbus, OH (YZ). Correspondence: Renee Stewart, APRN-DNP, 4242 Farnam St, Omaha, NE 68131; email: renstewart@nebraskamed.com.

Practice Points
  • Multidisciplinary care for older adults with multiple sclerosis (MS) should address geriatric issues, which can be done using a comprehensive geriatric assessment by providers in disciplines including but not limited to neurology, geriatrics, rehabilitation, social work, pharmacy, neuropsychology, psychology/psychiatry, nutrition, urology, ophthalmology, and audiology.
  • Providers should assess for health care access issues such as structural and financial barriers in older adults with MS.
  • Recognition of health care disparities facing older adults with MS, such as ageism and ableism, can improve quality of care.

The most recent estimate of the prevalence of multiple sclerosis (MS) in the United States is approaching 1 million individuals, with the highest peak prevalence between the ages of 55 and 64 years, followed by the 65- to 74-year-old age group, suggesting an increasing number of aging individuals.1This partly reflectsthe advances in disease-modifying therapies (DMTs) and supportive care that have extended the life expectancy of individuals with MS.2 Older adults with MS often have unique health care needs and challenges arising from worsening disability, comorbid conditions, and socioeconomic vulnerabilities. These issues require a comprehensive multidisciplinary approach to achieve a high-quality level of care. At the same time, access to health care in general is a documented challenge for both the general aging population and people with MS. Limited research has examined the intersection of aging and MS regarding multidisciplinary care and access to care. In this review, we discuss the known benefits of geriatric multidisciplinary care and challenges in access to care for older adults with MS, identify similar concepts from the general aging population, and address opportunities for improvement. Although the majority of cited literature originates from the US, we also included studies from other countries to capture relevant international perspectives.

Multidisciplinary Care

It is commonly accepted that multidisciplinary care is optimal for MS treatment, as advocated by both providers and patients.3,4 Older adults with MS experience unique issues related to aging and accumulating neurological disability, which require management by providers in disciplines including but not limited to neurology, geriatrics, rehabilitation, social work, pharmacy, neuropsychology, psychology/psychiatry, nutrition, urology, ophthalmology, and audiology (Table).

Table. The Roles of Multidisciplinary Specialists in the Comprehensive Geriatric Assessment of Older Adults With Multiple Sclerosis

Table. The Roles of Multidisciplinary Specialists in the Comprehensive Geriatric Assessment of Older Adults With Multiple Sclerosis

MS multidisciplinary care units integrate many of the aforementioned specialties,5 but they do not routinely perform a comprehensive geriatric assessment (CGA). In the primary care setting, integrated geriatric care has been shown to reduce medical costs and the number of prescription drugs used and to decrease the frequency of emergency department visits and hospitalizations of older adults who attended an integrated geriatric outpatient clinic compared with a nongeriatric clinic.6 Another study evaluating the effect of outpatient CGA-based care by a multidisciplinary team found improvements in frailty and mortality among older adults with multimorbidity.7

Currently, no studies have adequately evaluated whether team-based comprehensive management improves MS health care utilization or neurological function outcomes. Improved health care utilization refers to measurable changes in how people with MS use health care services that reflect more effective, appropriate, and efficient care.8In other neurological conditions such as stroke, CGA was associated with decreased hospital mortality and patients receiving more rehabilitation intervention and home health care.9

The results of a study by Bahri et al were encouraging. The study describes the implementation of a neurogeriatric MS clinic that provides same-day access to MS care, rehabilitation, nutrition, social work, pharmacy, and neuropsychology during a 4-hour clinic session for adults with MS aged 60 years or older.10 Providers in the clinic delivered a CGA covering functional capacity, cognition, mood, frailty, polypharmacy, nutrition, social/financial need, and goals of care. Recommendations were communicated to the patient, their neurologist, and their primary care physician. An initial survey of clinic participants reflected self-reported improvements in the quality of care.

Future research to evaluate the efficacy of multidisciplinary care in MS could include short-term measures such as the assessment of decision-making aligned with treatment guidelines and patient-reported outcomes, as well as long-term measures, such as assessment of DMT efficacy and safety and reducing claims for disability benefits.3 Additional areas of future research on multidisciplinary care for older adults with MS could include improving understanding of the perspectives of older adults with MS to align with their goals of care, developing pathways to implement CGA, methods to identify patients who benefit from such care, and evaluations of cost-effectiveness.

Barriers to Health Care Access

Penchansky and Thomas identified 5 dimensions of health care access: availability, accommodation, accessibility, affordability, and acceptability.11 Availability refers to the adequacy of the supply of services, including physicians, clinics, hospitals, and specialized programs, in relation to the needs and volume of clients. Accommodation focuses on how services are organized to meet client needs, such as appointment systems, hours of operation, walk-in options, and telephone services. Accessibility describes the geographic relationship between sites of services and client location, considering transportation, travel time, distance, and cost. Affordability is the cost of services relative to clients’ incomes, including insurance coverage, co-payments, and perceived value. Last, acceptability relates to a patient’s satisfaction with the delivery of equitable care. All of these affect the health care available to older adults with MS.

Individuals with MS who are aging often have complex and evolving health care needs, and addressing these needs requires access to coordinated, specialized care. MS is characterized by a high burden of chronic comorbidities, cognitive decline, and increasing physical disability10,11; these challenges increase with age. Disparities in access and quality of care are further influenced by social determinants of health, defined as the conditions in which people are born, grow, live, work, and age that affect health outcomes and contribute to inequities in disease progression, access to care, and quality of life12 (Figure).

Figure. Key Issues and Challenges to Health Care Access for Older Adults With MS

Figure. Key Issues and Challenges to Health Care Access for Older Adults With MS

Availability of Providers

Older adults with MS highly value access to trusted health care providers with expertise in MS13; however, many individuals with MS in the US live in a neurology desert, defined as living more than 60 miles from a neurologist. Specialist access particularly affects those in rural areas and in regions where there is a large number of people with disabilities who do not have insurance.14 A cross-sectional study of Medicare beneficiaries found that nearly 20% of those living with MS traveled 50 miles or more each way to access neurologic care, with older adults disproportionately affected.15 The shortage of MS clinicians is further exacerbated by the limited availability of geriatricians, who provide value n managing the complex medical, cognitive, and psychosocial needs of aging individuals. While the US Department of Health and Human Services projects growth in the number of geriatricians, a projected shortfall of nearly 27,000 physicians remains concerning, especially in rural areas, where only approximately 10% of geriatricians currently practice.16

Increased Need for Care

A 2015 systematic review of cross-sectional studies found that individuals with MS commonly experience a high burden of comorbidities.17 The prevalence of many of these comorbid conditions increases with age, including hypertension, hyperlipidemia, diabetes, ischemic heart disease, cerebrovascular disease, and chronic lung disease. This age-related rise in comorbidity burden was most recently described in a meta-analysis of 14 clinical trials that included over 17,000 individuals with MS. The study reported that people with MS over the age of 50 were 5 times more likely to be diagnosed with hypertension compared with those between 30 and 40 years of age.18 The cohort of individuals aged 50 years or older was also 3.5 times more likely to be diagnosed with diabetes and 5 to 6 times more likely to have ischemic heart disease and cerebrovascular disease.These individuals tend to be high utilizers of health care services and face increased risks of adverse health outcomes, underscoring the need for improved, coordinated systems of care.

In the general aging population, cognitive impairment also plays a pivotal role in shaping health care access.Between 12% and 18% of US adults over age 60 have mild cognitive impairment. These individuals often have difficulty managing appointments, using telehealth platforms, advocating for themselves, and conveying accurate medical histories.19Cognitive deficits are well documented in people with MS and have a greater association in those of both older age and higher levels of disability. These overlapping factors may contribute to a compounding effect, further limiting health care access and exacerbating challenges as individuals with MS age.20

Transportation Barriers

Older adults with MS often face transportation challenges. Chiu et al reviewed barriers to the accessibility and continuity of health care services for people with MS and highlighted that transportation barriers significantly impact their ability to attend medical appointments, which can lead to delays in care and potential deterioration of health outcomes.21 The study emphasized the need for health care systems to address these barriers by implementing more accessible transportation options and improving the overall accessibility of health care facilities to better serve people with MS.16 Similar studies among the general aging population show the same, as about 20% of older adults do not drive and up to one-third face driving restrictions.22 A qualitative study in rural communities identified 5 primary barriers to care, with limited transportation being the most prevalent. The additional barriers noted were limited health care supply (eg, fewer per capita hospital beds, doctors, nurses, and other health care services), lack of quality health care (eg, concerns about provider competence and service quality), social isolation, and financial constraints.16

Financial Challenges

Income plays a critical role in determining an individual’s ability to address their health care needs. Limited financial resources can restrict access to essential services, including specialist visits, transportation, medications, assistive devices, and home- and community-based services. When looking at people with MS without distinguishing by age, direct medical costs (eg, doctor’s appointments and medications) are the biggest contributor to the high cost of MS. The cost of living with MS in the US is estimated to be $88,487 annually, and the average lifetime cost of care for a person with MS exceeds $4 million.23 The annual US economic burden (ie, the societal cost)—including individuals living with MS, the government (federal, state, and local), employers, health insurers, and more—is $85.4 billion.

We know that when the cost of health care becomes a significant financial burden, patients often forgo health care to afford other essential needs. A Canadian study showed that a cohort of older people with MS, who described themselves as financially challenged, prioritized housing, food, and transportation over their health care needs.13 In older adults living in the US, health-related quality of life was found to be significantly associated with household income.24 In 2022, 5.9 million people 65 years or older lived below the poverty level, and another 2.7 million had incomes at or just above the poverty level (near-poor).25 This economic insecurity contributes to older adults missing provider visits, skipping recommended medical tests or treatment, not filling prescription medications, and taking less medication than prescribed or skipping doses.25 Despite decreased rates of uninsured older adults after the implementation of Medicare, cost remains a barrier to care access.26

Health Equity and Access Disparities

People with MS and significant disability also face extensive challenges in nearly all facets of health care delivery, particularly access to care.24,25 While mobility impairments are a primary barrier to receiving comprehensive and coordinated care, these difficulties are compounded by inaccessible, fragmented health care systems and societal issues.6,26 Further, structural ageism and ableism within health care systems can marginalize older adults.27 Ageism refers to stereotypes, biases, and discriminatory behaviors based on age. Similarly, ableism involves these same prejudices and discriminatory attitudes, but in relation to disability. Race and ageism also have an amplifying effect on aging individuals from marginalized communities and can lead to increased disparities in social determinants of health, including poor access to health care and poor health outcomes.28

Discussion

There are limited studies addressing multidisciplinary care and access to care in older adults with MS. However, there is more literature on geriatric care in the general population supporting the value of a multidisciplinary approach, including the use of the comprehensive geriatric assessment. As outlined in the 2024 MS and Aging Consensus Statement by the Consortium of Multiple Sclerosis Centers, utilizing an access-to-care framework allows a significant opportunity to enhance care for aging individuals with MS.29

Considering these dimensions will allow health care systems to recognize and comprehensively address barriers to care.30 Highlighting how social disparities affect access, particularly among individuals with multiple risk factors, is essential. The National Institutes of Health’s NIMHD Research Framework (developed by the National Institute on Minority Health and Health Disparities) offers a valuable approach to understanding Health Disparities) offers a valuable approach to understanding and addressing these barriers.31 Research specifically targeting aging individuals with MS is urgently needed. Distributing a needs-based assessment through a known MS registry, such as the North American Research Committee on Multiple Sclerosis Registry, could begin to identify and address common barriers.

Access to coordinated, person-centered care has been shown to improve patient satisfaction and perceived health among older adults with MS.4 Incorporating palliative care principles, such as aligning care with patients’ priorities, could enhance patient satisfaction and improve care delivery for the complex needs of this population.32 As people with MS continue to age and lose function, health interventions must account for the diverse ability levels of older adults. For aging individuals with disability, the concept of successful aging is unique. Their experiences offer key insights as they have adapted to and lived with loss of function over time. A qualitative study by Molton and Yorkston highlights the complex nature of successful aging among individuals with physical disabilities extending beyond those living with MS.33 A comprehensive, tightly integrated, community house call practice has been shown to be a viable solution to improve care for people with MS experiencing significant disability.34 In recent years, there has been a resurgence of home-based primary care services in the US, due to the needs of our aging society.35 The expansion of alternative care models such as home-based services offers the potential to improve access to care for aging individuals with MS, particularly for those with significant disability, and could offer an opportunity to address both MS and primary care needs while removing transportation barriers.

Policy reforms are needed to support efforts to expand access to care and ensure adequate payment models. Expanding and protecting telehealth services is of particular interest, given the prevalence of neurology deserts and the nationwide shortage of geriatricians. Hubs in community-based centers, with staff available to provide in-person aid, could be used by older adults who need more technical support.36 Reducing structural and attitudinal barriers, as well as supporting community-based programs that specialize in addressing unmet needs, could further support equitable access to care for aging people with MS.

Conclusions

Older adults with MS have unique health care needs that benefit from having a multidisciplinary provider team with a specialization in geriatric care; at the same time, health care access barriers hinder this patient population from receiving optimal care. By developing awareness, providing training in recognizing geriatric issues and circumventing health care barriers, and advancing understanding through research, clinicians can better serve the needs of the growing population of aging people with MS.

Disclosures: Renee Stewart, DNP, APRN, has been on an advisory board for Genentech. Rachael Stacom, NP, has served on advisory boards for Genentech and TG Therapeutics. Jacquelyn Bainbridge, PharmD, has served on advisory boards for EMD-Serono, Novartis, and TG Therapeutics. Jeff Wilken, PhD, has been a speaker for Biogen, EMD Serono, and Sanofi; a paid consultant for Bayer and Sanofi; and has received research funding from Biogen and Sanofi. John R. Corboy, MD, MA, has received compensation as the medical director of the Rocky Mountain MS Center and associate editor of the Annals of Neurology. He has received research support from EMD Serono, the National Institutes of Health via the Immune Tolerance Network, and the National Multiple Sclerosis Society. Ruth Ann Marrie, MD, PhD, FRCPC, receives research funding from the Arthritis Society, the Canadian Institutes of Health Research, Children’s Hospital Research Institute of Manitoba, Consortium of Multiple Sclerosis Centers, Crohn’s and Colitis Canada, Manitoba Medical Service Foundation, MS Canada, National Multiple Sclerosis Society, Pfizer Foundation, Public Health Agency of Canada, and the US Department of Defense. She is a coinvestigator on studies receiving funding from Biogen Idec and Roche Canada, and holds the Gillian Hope Multiple Sclerosis Clinical Research Chair (Dalhousie University). Le H. Hua, MD, has received personal fees for speaking, consulting, and advisory board activities from Alexion, EMD Serono, Genentech, Genzyme, Horizon, Novartis, and TG Therapeutics, and has had research support paid to her institution from Genentech outside the submitted work. Frederick W. Foley, PhD, has been on advisory boards for Bayer and Biogen; has been a paid consultant for Biogen; and has been a speaker for EMD Serono and Sanofi. Authors Patty Bobryk, MHS, PT, MSCS, ATP; Jennifer S. Graves, MD, PhD, MAS; Mona D. Bostick, RDN, LDN; Maureen T. Choman, MD; Scott D. Newsome, DO, MSCS; Sarah A. Morrow, MD, FRCPC, MS; and Yinan Zhang, MD, have declared no relevant disclosures.

Acknowledgments: This manuscript stems from presentations and discussions at the Consortium of Multiple Sclerosis Centers’ (CMSC) Aging and MS Consensus Conference held June 1 and 2, 2024, and is based on the CMSC publication “MS and Aging: A Summary Statement from a CMSC Consensus Conference.”

References

  1. Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029-e1040. doi:10.1212/WNL.0000000000007035

  2. Vaughn CB, Jakimovski D, Kavak KS, et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol. 2019;15(6):329-342. doi:10.1038/s41582-019-0183-3

  3. Soelberg Sorensen P, Giovannoni G, Montalban X, Thalheim C, Zaratin P, Comi G. The multiple sclerosis care unit. Mult Scler. 2019;25(5):627-636. doi:10.1177/1352458518807082

  4. Chiu C, Park M, Hoffman T, Campbell M, Bishop M. Descriptive analysis of free-text comments on healthcare priorities and experiences in a national sample of people with multiple sclerosis. Mult Scler Relat Disord. 2019;34:141-149. doi:10.1016/j.msard.2019.06.023

  5. Feys P, Giovannoni G, Dijsselbloem N, Centonze D, Eelen P, Lykke Andersen S. The importance of a multi-disciplinary perspective and patient activation programmes in MS management. Mult Scler. 2016;22(suppl 2):34-46. doi:10.1177/1352458516650741

  6. Wei YJ, Hsieh CF, Huang YT, Huang MS, Fang TJ. The influence of integrated geriatric outpatient clinics on the health care utilization of older people. BMC Geriatr. 2020;20(1):379. doi:10.1186/s12877-020-01782-7

  7. Mazya AL, Garvin P, Ekdahl AW. Outpatient comprehensive geriatric assessment: effects on frailty and mortality in old people with multimorbidity and high health care utilization. Aging Clin Exp Res. 2019;31(4):519-525. doi:10.1007/s40520-018-1004-z

  8. Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res. 1974;9(3):208-220.

  9. Hosoi T, Yamana H, Tamiya H, et al. Association between comprehensive geriatric assessment and short-term outcomes among older adult patients with stroke: a nationwide retrospective cohort study using propensity score and instrumental variable methods. EClinicalMedicine. 2020;23:100411. doi:10.1016/j.eclinm.2020.100411

  10. Bahri M, Epstein K, Stevens E, Rosko AE, Maturu S, Zhang Y. Implementing a multidisciplinary approach for older adults with multiple sclerosis: geriatric neurology in practice. Mult Scler Relat Disord. 2024;92:105952. doi:10.1016/j.msard.2024.105952

  11. Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127-140. doi:10.1097/00005650-198102000-00001

  12. Dobson R, Rice DR, D’hooghe M, et al. Social determinants of health in multiple sclerosis. Nat Rev Neurol. 2022;18(12):723-734. doi:10.1038/s41582-022-00735-5

  13. Ploughman M, Deshpande N, Latimer-Cheung AE, Finlayson M. Drawing on related knowledge to advance multiple sclerosis falls-prevention research. Int J MS Care. 2014;16(4):163-170. doi:10.7224/1537-2073.2014-052

  14. McGinley MP, Harvey T, Lopez R, Ontaneda D, Buchalter RB. Geographic disparities in access to neurologists and multiple sclerosis care in the United States. Neurology. 2024;102(2):e207916. doi:10.1212/WNL.0000000000207916

  15. Lin CC, Hill CE, Kerber KA, et al. Patient travel distance to neurologist visits. Neurology. 2023;101(18):e1807-e1820. doi:10.1212/WNL.0000000000207810

  16. Goins RT, Williams KA, Carter MW, Spencer M, Solovieva T. Perceived barriers to health care access among rural older adults: a qualitative study. J Rural Health. 2005;21(3):206-213. doi:10.1111/j.1748-0361.2005.tb00084.x

  17. Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21(3):263-281. doi:10.1177/1352458514564491

  18. Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA. Investigating the prevalence of comorbidity in multiple sclerosis clinical trial populations. Neurology. 2024;102(5):e209135. doi:10.1212/WNL.0000000000209135

  19. Portacolone E, Nguyen TT, Bowers BJ, et al. Perceptions of the role of living alone in providing services to patients with cognitive impairment. JAMA Netw Open. 2023;6(8):e2329913. doi:10.1001/jamanetworkopen.2023.29913

  20. Ruano L, Portaccio E, Goretti B, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2017;23(9):1258-1267. doi:10.1177/1352458516674367

  21. Chiu C, Bishop M, Pionke JJ, Strauser D, Santens RL. Barriers to the accessibility and continuity of health-care services in people with multiple sclerosis: a literature review. Int J MS Care. 2017;19(6):313-321. doi:10.7224/1537-2073.2016-016

  22. Ryvicker M, Bollens-Lund E, Ornstein KA. Driving status and transportation disadvantage among Medicare beneficiaries. J Appl Gerontol. 2020;39(9):935-943. doi:10.1177/0733464818806834

  23. Bebo B, Cintina I, LaRocca N, et al. The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs. Neurology. 2022;98(18):e1810-e1817. doi:10.1212/WNL.0000000000200150

  24. Huguet N, Kaplan MS, Feeny D. Socioeconomic status and health-related quality of life among elderly people: results from the Joint Canada/United States Survey of Health. Soc Sci Med. 2008;66(4):803-810. doi:10.1016/j.socscimed.2007.11.011

  25. Dusetzina SB, Besaw RJ, Whitmore CC, et al. Cost-related medication nonadherence and desire for medication cost information among adults aged 65 years and older in the US in 2022. JAMA Netw Open. 2023;6(5):e2314211. doi:10.1001/jamanetworkopen.2023.14211

  26. Osborn R, Doty MM, Moulds D, Sarnak DO, Shah A. Older Americans were sicker and faced more financial barriers to health care than counterparts in other countries. Health Aff (Millwood). 2017;36(12):2123-2132. doi:10.1377/hlthaff.2017.1048

  27. Chang ES, Kannoth S, Levy S, Wang SY, Lee JE, Levy BR. Global reach of ageism on older persons’ health: a systematic review. PLoS One. 2020;15(1):e0220857. doi:10.1371/journal.pone.0220857

  28. Farrell TW, Hung WW, Unroe KT, et al. Exploring the intersection of structural racism and ageism in healthcare. J Am Geriatr Soc. 2022;70(12):3366-3377. doi:10.1111/jgs.18105

  29. Consortium of Multiple Sclerosis Centers. MS and Aging: A Summary Statement from a CMSC Consensus Conference. October 2024. Accessed July 9, 2026. https://mscare.sharefile.com/share/view/seac2c8f520f14ddb97323b076dd0f087

  30. Adigun S. Toward an emerging model of healthcare access: a theoretical framework. Int Nurs Rev. 2024;71(3):424-431. doi:10.1111/inr.12867

  31. Hill CV, Pérez-Stable EJ, Anderson NA, Bernard MA. The National Institute on Aging Health Disparities Research Framework. Ethn Dis. 2015;25(3):245-254. doi:10.18865/ed.25.3.245

  32. Chan LML, Yan OY, Lee JJJ, et al. Effects of palliative care for progressive neurologic diseases: a systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24(2):171-184. doi:10.1016/j.jamda.2022.11.001

  33. Molton IR, Yorkston KM. Growing older with a physical disability: a special application of the successful aging paradigm. J Gerontol B Psychol Sci Soc Sci. 2017;72(2):290-299. doi:10.1093/geronb/gbw122

  34. Healey K, Zabad R, Young L, et al. Multiple Sclerosis at Home Access (MAHA): an initiative to improve care in the community. Int J MS Care. 2019;21(3):101-112. doi:10.7224/1537-2073.2018-006

  35. Cornwell T, Plencner B. House calls: providing care beyond the office walls. Fam Pract Manag. 2021;28(3):22A-22G.

  36. Leff B, Ritchie CS, Rising KL, Cannon K, Wardlow L. Addressing barriers to equitable telehealth for older adults. Front Med (Lausanne). 2025;12:1483366. doi:10.3389/fmed.2025.1483366

Related Videos
IJMSC January 2026 Research
IJMSC December Research